The HSE wishes to invite tenders from suitable suppliers to undertake an external evaluation of the 18 month pilot Medically Supervised Injecting Facility at Merchants Quay Ireland, 13-14 Merchant's Quay, The Liberties, Dublin, and D08 KT61. The evaluation is required to take place at 6 and 18 months, in line with planning permission and the licence to operate as per Misuse of Drugs (Supervised Injecting Facilities) Act 2017. The Misuse of Drugs (Supervised Injecting Facilities) Act 2017 Act defines a supervised injecting facility as "a facility operated by a licence holder where authorised users may consume drugs by injection." and the Act enables the Minister to issue licenses to operate a supervised injecting facility. This allows for the establishment, licensing, operation and regulation of supervised injecting facility on a pilot basis. As a result of this legislation (and following a tender process), the HSE awarded the contract to provide a medically supervised injecting facility to Merchants Quay Ireland (MQI). MQI subsequently applied and obtained planning permission to pilot a medically supervised injecting facility in its Riverbank Centre, Dublin 8. It is anticipated that this facility will be operational in quarter four 2024 and will run for an 18 month pilot phase.
Deadline
The time limit for receipt of tenders was 2024-11-28.
The procurement was published on 2024-10-24.
Contract notice (2024-10-24) Object Scope of the procurement
Title: Evaluation of Pilot Medically Supervised Injecting Facility
Short description:
โThe HSE wishes to invite tenders from suitable suppliers to undertake an external evaluation of the 18 month pilot Medically Supervised Injecting Facility...โ
Short description
The HSE wishes to invite tenders from suitable suppliers to undertake an external evaluation of the 18 month pilot Medically Supervised Injecting Facility at Merchants Quay Ireland, 13-14 Merchant's Quay, The Liberties, Dublin, and D08 KT61. The evaluation is required to take place at 6 and 18 months, in line with planning permission and the licence to operate as per Misuse of Drugs (Supervised Injecting Facilities) Act 2017. The Misuse of Drugs (Supervised Injecting Facilities) Act 2017 Act defines a supervised injecting facility as "a facility operated by a licence holder where authorised users may consume drugs by injection." and the Act enables the Minister to issue licenses to operate a supervised injecting facility. This allows for the establishment, licensing, operation and regulation of supervised injecting facility on a pilot basis. As a result of this legislation (and following a tender process), the HSE awarded the contract to provide a medically supervised injecting facility to Merchants Quay Ireland (MQI). MQI subsequently applied and obtained planning permission to pilot a medically supervised injecting facility in its Riverbank Centre, Dublin 8. It is anticipated that this facility will be operational in quarter four 2024 and will run for an 18 month pilot phase.
Show more
Type of contract: Services
Products/services: Social research services๐ฆ
Estimated value excluding VAT: 75 000 EUR ๐ฐ
Information about lots
This contract is divided into lots โ
Tenders may be submitted for maximum number of lots: 2
Tenders may be submitted for all lots โ
1๏ธโฃ
Description of the procurement:
โThe HSE wishes to invite tenders from suitable suppliers to undertake an external evaluation of the 18 month pilot Medically Supervised Injecting Facility...โ
Description of the procurement
The HSE wishes to invite tenders from suitable suppliers to undertake an external evaluation of the 18 month pilot Medically Supervised Injecting Facility at Merchants Quay Ireland, 13-14 Merchant's Quay, The Liberties, Dublin, and D08 KT61. The evaluation is required to take place at 6 and 18 months, in line with planning permission and the licence to operate as per Misuse of Drugs (Supervised Injecting Facilities) Act 2017. The Misuse of Drugs (Supervised Injecting Facilities) Act 2017 Act defines a supervised injecting facility as "a facility operated by a licence holder where authorised users may consume drugs by injection." and the Act enables the Minister to issue licenses to operate a supervised injecting facility. This allows for the establishment, licensing, operation and regulation of supervised injecting facility on a pilot basis. As a result of this legislation (and following a tender process), the HSE awarded the contract to provide a medically supervised injecting facility to Merchants Quay Ireland (MQI). MQI subsequently applied and obtained planning permission to pilot a medically supervised injecting facility in its Riverbank Centre, Dublin 8. It is anticipated that this facility will be operational in quarter four 2024 and will run for an 18 month pilot phase.
2๏ธโฃ
Place of performance: Dublin๐๏ธ Title
Lot Identification Number: LOT-0002
Procedure Type of procedure
Open procedure โ Administrative information
Time limit for receipt of tenders or requests to participate: 2024-11-28 12:00:00 ๐
Conditions for opening of tenders: 2024-11-28 12:30:00 ๐
Conditions for opening of tenders (place): https://www.etenders.gov.ie/epps/cft/prepareViewCfTWS.do?resourceId=4561574
Languages in which tenders or requests to participate may be submitted: English ๐ฃ๏ธ
Complementary information Review body
Name: The High Court of Ireland
National registration number: The High Court of Ireland
Postal address: Four Courts, Inns Quay, Dublin 7
Postal code: D07 WDX8
Postal town: Dublin
Country: Ireland ๐ฎ๐ช
E-mail: highcourtcentraloffice@courts.ie๐ง
Phone: +353 1 8886000๐ Information about electronic workflows
Electronic invoicing will be accepted
Source: OJS 2024/S 210-654382 (2024-10-24)